2013-12-03 18:18:57 UTC

Liver Stiffness Can Determine Risk Level in Patients with CLDs

Dec. 5, 2013

Reporting in Clinical Gastroenterology and Hepatology, Siddharth Singh and colleagues find that the degree of liver stiffness is associated with risk of decompensated cirrhosis, hepatocellular carcinoma and death in patients with chronic liver diseases (CLDs).

Liver stiffness measurement (LSM), using elastography, can independently predict outcomes of patients with chronic liver diseases (CLDs). However, there is much variation in reporting and consistency of findings. Siddharth Singh and colleagues performed a systematic review and meta-analysis to evaluate the association between LSM and outcomes of patients with CLDs. Reporting in Clinical Gastroenterology and Hepatology, they find that the degree of liver stiffness is associated with risk of decompensated cirrhosis, hepatocellular carcinoma and death in patients with CLDs. LSM therefore might be used in risk stratification.

Clinical Gastroenterology and Hepatology 2013: 11(12): 1573-1584.e2

More on Cirrhosis

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis

Oct. 11, 2017

Statin use is probably associated with lower risk of hepatic decompensation and mortality, and might reduce portal hypertension, in patients with CLDs.

Cirrhosis Presenting as Cutaneous Calciphylaxis

Oct. 11, 2017

A 73-year-old woman with a history of hypertension presented with a 3-month history of a painful, non-healing right calf ulcer and 2–3 weeks of painful, dusky purple patches on the right thigh.